These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22617568)

  • 1. Catalase polymorphisms and metabolic diseases.
    Hebert-Schuster M; Fabre EE; Nivet-Antoine V
    Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):397-402. PubMed ID: 22617568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polymorphisms of PPARs and metabolic disorders].
    Araki E; Igata M; Motoshima H; Tsuruzoe K
    Nihon Rinsho; 2005 Apr; 63(4):617-22. PubMed ID: 15828229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An association study between catalase -262C>T gene polymorphism, sodium-lithium countertransport activity, insulin resistance, blood lipid parameters and their response to atorvastatin, in Greek dyslipidaemic patients and normolipidaemic controls.
    Kosmidou M; Hatzitolios AI; Molyva D; Raikos N; Savopoulos C; Daferera N; Kokkas V; Goulas A
    Free Radic Res; 2009 Apr; 43(4):385-9. PubMed ID: 19274593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
    Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population.
    Al-Daghri NM; Al-Attas OS; Alokail MS; Alkharfy KM; Hussain T; Yakout S; Vinodson B; Sabico S
    Gene; 2012 Feb; 493(1):142-7. PubMed ID: 22155316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human catalase gene promoter haplotype and cardiometabolic improvement after bariatric surgery.
    Alili R; Nivet-Antoine V; Saldmann A; Golmard JL; Cottart CH; Laguillier C; Giral P; Beaudeux JL; Bouillot JL; Poitou C; Clément K; Hébert-Schuster M
    Gene; 2018 May; 656():17-21. PubMed ID: 29496557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Aβ production prompts the onset of glucose intolerance and insulin resistance.
    Jiménez-Palomares M; Ramos-Rodríguez JJ; López-Acosta JF; Pacheco-Herrero M; Lechuga-Sancho AM; Perdomo G; García-Alloza M; Cózar-Castellano I
    Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1373-80. PubMed ID: 22414803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population.
    Romeo S; Sentinelli F; Cavallo MG; Leonetti F; Fallarino M; Mariotti S; Baroni MG
    Int J Obes (Lond); 2008 Mar; 32(3):413-20. PubMed ID: 17912268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of genetic variations in HHEX gene on insulin metabolism in the German MESYBEPO cohort.
    Pivovarova O; Nikiforova VJ; Pfeiffer AF; Rudovich N
    Diabetes Metab Res Rev; 2009 Feb; 25(2):156-62. PubMed ID: 19117022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance.
    Mager U; Kolehmainen M; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto JO; Pulkkinen L; Uusitupa MI;
    Am J Hypertens; 2006 Sep; 19(9):920-6. PubMed ID: 16942934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease.
    Crawford A; Fassett RG; Geraghty DP; Kunde DA; Ball MJ; Robertson IK; Coombes JS
    Gene; 2012 Jun; 501(2):89-103. PubMed ID: 22525041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the clusterin gene polymorphisms with type 2 diabetes mellitus.
    Daimon M; Oizumi T; Karasawa S; Kaino W; Takase K; Tada K; Jimbu Y; Wada K; Kameda W; Susa S; Muramatsu M; Kubota I; Kawata S; Kato T
    Metabolism; 2011 Jun; 60(6):815-22. PubMed ID: 20850846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance.
    González-Sánchez JL; Zabena CA; Martínez-Larrad MT; Fernández-Pérez C; Pérez-Barba M; Laakso M; Serrano-Ríos M
    Obes Res; 2005 May; 13(5):807-12. PubMed ID: 15919831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of RBP4 gene variants and serum HDL cholesterol levels in the Newfoundland population.
    Shea JL; Loredo-Osti JC; Sun G
    Obesity (Silver Spring); 2010 Jul; 18(7):1393-7. PubMed ID: 19893506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in the lamin A/C gene: associations with metabolic syndrome.
    Steinle NI; Kazlauskaite R; Imumorin IG; Hsueh WC; Pollin TI; O'Connell JR; Mitchell BD; Shuldiner AR
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1708-13. PubMed ID: 15205219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between eight adiponectin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers.
    Boumaiza I; Omezzine A; Rejeb J; Rebhi L; Rejeb NB; Nabli N; Abdelaziz AB; Bouslama A
    Metab Syndr Relat Disord; 2011 Dec; 9(6):419-26. PubMed ID: 21870907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between mu-opioid receptor-1 102T>C polymorphism and intermediate type 2 diabetes phenotypes: results from the Quebec Family Study (QFS).
    Ruchat SM; Girard M; Weisnagel SJ; Bouchard C; Vohl MC; Pérusse L
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1018-22. PubMed ID: 18518884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight.
    Goyenechea E; Parra D; Martínez JA
    Metabolism; 2007 Dec; 56(12):1643-8. PubMed ID: 17998015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.